HOME2019-03-11T17:27:49+00:00

The PD-MitoQUANT Project

Today, more than one million people live with Parkinson’s in Europe and this number is forecast to double by 2030. New, more effective treatments are urgently needed – but researchers and companies developing new drugs need to know more about how mitochondrial dysfunction is involved in disease progression and better models are needed for drug discovery and development.

PD-MitoQUANT is an Innovative Medicines Initiative (IMI) project that brings together academic experts, SMEs, pharmaceutical companies from the European Federation of Pharmaceutical Industries and Associations (EFPIA) and patient advocacy organisation Parkinson’s UK to:

  • improve our understanding of mitochondrial dysfunction in Parkinson’s,

  • identify and validate molecular drivers and mechanisms in Parkinson’s, and

  • discover innovative therapeutic targets that can be further progressed by the EFPIA partners in the future.

Latest News

PD-MitoQUANT makes headlines

March 19th, 2019|

Here is a list of international and national media coverage of the launch of PD-MitoQUANT: Bioengineer.org: Ireland to lead €7 million Parkinson's research project. Read the story here. SCIENMAG: Ireland to lead €7 million Parkinson's research project. Read the story here. Hospital Pharmacy Europe: Ireland to lead on €7 million Parkinson's research project. Read [...]

PD-MitoQUANT Official Press release- 12 March 2019

March 12th, 2019|

7 million euro awarded for Parkinson’s research through Innovative Medicines Initiative   New, more effective treatments are urgently needed for the more than one million people living with Parkinson’s in Europe today. While there are therapies available for the condition, they do not improve all symptoms, nor do they slow [...]

Successful Kickoff Meeting in Dublin

March 11th, 2019|

The PD-MitoQUANT team had a very successful kick-off meeting last week in RCSI! We reviewed our work plan and discussed the planned activities for the first year of the project. We're going to be busy! To learn more about the project, check out our Project page. If you're on twitter, [...]

Read more